INOmax

DRUG3 trials

Sponsors

Mallinckrodt, Medical College of Wisconsin, RoseLab Skin Optics Laboratory

Conditions

CREST SyndromeCalcinosis CutisInflammationPlatelet DysfunctionPulmonary Hypertension of NewbornRaynaud Phenomenon

Phase 2

Nitric Oxide Administration During Pediatric Cardiopulmonary Bypass Surgery to Prevent Platelet Activation

CompletedNCT03455218

Medical College of WisconsinInflammation, Platelet Dysfunction

Start: 2018-04-25End: 2019-05-05Updated: 2020-08-13

Unknown Phase

Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension

TerminatedNCT03132428

MallinckrodtPulmonary Hypertension of Newborn

Start: 2017-07-27End: 2020-02-11Updated: 2020-06-18

Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon

RoseLab Skin Optics LaboratoryCalcinosis Cutis, CREST Syndrome, Raynaud Phenomenon

Start: 2019-06-20End: 2019-09-01Target: 5Updated: 2019-06-03

Related Papers

Use of inhaled nitric oxide in preterm vs term/near-term neonates with pulmonary hypertension: results of the PaTTerN registry study.

2021-10-2815 citations